A class of drugs called CCR5 antagonists has revolutionized the care of HIV patients. These meds slow the disease from progressing to full-blown AIDS. A new preclinical study demonstrates these drugs may also be useful in cancer.

HER2-positive breast cancer is one of the most aggressive forms of the disease. It tends to grow and spread rapidly. An experimental drug may halt this beast and offer a gentler ride for women living with it .

The female hormone estrogen can wreak havoc on a woman's body if it it gets out of hand, promoting the development of breast and endometrial (uterine) cancers.

Nobody walks away from breast cancer scot-free. The best of treatments leave the ladies of breast cancer changed, sometimes for years. Research confirms that fitness levels matter. A lot.

Breast cancers that have high levels of HER2 are particularly aggressive. Not only do they grow rapidly, but they tend to return after treatment. A vaccine currently being investigated appears to be effective in preventing this reappearing act.

Imagine that instead of toxic chemotherapies, natural compounds in foods could be used to fight back against aggressive cancers. Celery and parsley may be vegetable gems of the future.

You've heard stories about a compound found in plastics called BPA. It's been linked to all sorts of health issues. So what about BPA and breast cancer?

You remember the scene in "Forrest Gump" where his friend Jenny urges him to "Run Forrest run!" to get away from a pesky group of kids. He takes off, the braces that have been shackling him fly off. And he's free.

Though still rare, when breast cancer shows up in women in their 30s , it's not a kinder, gentler form of the disease. Quite the opposite. Scientists are beginning to understand why this is and what interventions might calm its cruelty.

When a woman has a baby, the cells of her unborn child circulate in her body for decades after childbirth. Likewise, some of her cells are in the body of her child for years, too. This is called microchimerism .